ACROBiosystems’ cover photo
ACROBiosystems

ACROBiosystems

Biotechnology Research

Newark, Delaware 30,464 followers

Where Proteins and Innovation Advance Biomedicine

About us

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises of several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics. ACROBiosystems’ brands include FLAG, Star Staining, ViruStop, Aneuro, ComboX, GENPower, and many others. Its main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics. Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and its clinical applications, and contributes to global health.

Industry
Biotechnology Research
Company size
501-1,000 employees
Headquarters
Newark, Delaware
Type
Public Company
Founded
2010
Specialties
Proprietary HEK293 expression platform, In-house developed enzymatic and chemical biotin labeling technique, covid-19 antigens and antibodies, CAR-T, Reagents for COVID-19 vaccine development and evaluation, SARS-CoV-2 Related Kit Products, Targets for Antibody-Drug Conjugates, Hot target for bispecific antibody, CD3, Bispecific Antibody, Sars-cov-2 mutants, ADCs, Sars-cov-2 kits, Targets for CAR-T Cell Therapy, Multi-pass Transmembrane Proteins and Technology Platforms, Immune Checkpoint, Cytokine, BsAb targets, Fc Receptors, MABSOL Biotinylated Protein, Enzymes, Anti-idiotypic Antibodies, Cell Gene Therapy, and GMP grade Cytokines

Locations

Employees at ACROBiosystems

Updates

  • 🚀 Exciting News from ACROBiosystems! 🚀 We are thrilled to unveil our new state-of-the-art GMP facility, purpose-built to tackle the unique challenges of the cell and gene therapy (CGT) sector with our Resilient Supply brand—your assurance of flexible, high-quality solutions coupled with steadfast global supply and comprehensive regulatory support. Resilient Highlights: - Robust Global Supply: Multi-point distribution ensures continuous availability. - Regulatory Excellence: Compliant with EU, US, and China regulations for unparalleled reliability. - Advanced GMP Quality Management: Upholds superior standards - Cost-effective outcomes. From immunotherapy and stem cells to organoids, we offer innovative products like: - CelThera™ GMP T Cell Expansion Medium - iPSC Culture Solution Laminin 511 Mix & Go ECM Protein - GMP-grade DLL4 Protein for feeder-free NK cell differentiation - Regulatory-compliant rapid test kits, fully validated, significantly shortening cell therapy drug release cycles Our Resilient Supply products and solutions cover the entire drug development process from early discovery, process development and production, characterization and quality control, and safety testing, to clinical research. #CGT #CellTherapy #GeneTherapy #GMP #Biotechnology #Innovation #ACROBiosystems

  • #ACROStory #WomenInSTEM At ACROBiosystems, we believe leadership is about bridging vision with action. Today, we’re proud to spotlight Charm Chen Xiamin Chen, our VP of North America Operations, whose multidimensional expertise and passion are reshaping what it means to lead in STEM. 🔹 Strategic Planning: Developing and implementing commercial strategies aligned with company goals. 🔹 Sales and Marketing: Overseeing sales operations, marketing initiatives, and customer relationship management. 🔹 Financial Acumen: Managing budgets, forecasting revenue, and ensuring profitability. 🔹 Leadership: Leading and mentoring teams, fostering a collaborative and high-performance culture. 🔹 Operational Efficiency: Streamlining processes to improve efficiency and productivity Her Mantra: "What fuels me? The relentless pursuit of knowledge – and breaking barriers in fields where women’s voices are essential yet underrepresented." To Women in STEM: "Embrace curiosity. Stay resilient. Your unique perspective isn’t just valuable – it’s revolutionary." 📣 👉 Join the conversation: Who inspires YOU to challenge norms in STEM? Tag them below! ⤵ #WomenInSTEM #LeadershipUnleashed #OperationalExcellence #BreakTheBias #STEMInnovators

    • No alternative text description for this image
  • #MeetwithACRO [ACRO Event - UK] Last Day at NextGen Biomed 2025! 🎉 Time flies, and we’re already on the final day of the conference! We’ll be here at Booth #30 until 2:15 PM, so don’t miss your last chance to stop by. 🎨 Join us for a fun activity—draw a face and take home an ACRO Green tote bag! 🦙 And of course, don’t forget to check out our llamas! It’s been an incredible event connecting with so many of you. Let’s make the last day just as exciting! #NextGenBiomed2025 #NGB2025 #ACROBiosystems #Biotech #LifeSciences #EndotoxinTesting #Sustainability #Networking

    • No alternative text description for this image
    • No alternative text description for this image
  • #MeetwithACRO [ACRO Event - Tours, France] 🚀 ACROBiosystems is excited to sponsor CONGRÈS FRANCE BIOPRODUCTION! We’re excited to be part of CONGRÈS FRANCE BIOPRODUCTION, where industry leaders will explore the latest advancements in biomanufacturing. From AI-driven innovation to new production models, this event is shaping the future of biotherapeutics! Visit Stand No.65 to meet with Mesure Turkes and Idil Arioz to discover how ACRO can support the next generation of biopharma. Let’s connect and drive innovation together! 🚀 Looking forward to seeing you there! 👋

    • No alternative text description for this image
  • On February 5, 2024, Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody jointly developed with Kelun-Biotech Medicine for the treatment of Chronic Obstructive Pulmonary Disease (COPD), has been approved by the National Medical Products Administration (NMPA) in China. This marks the official entry of the innovative antibody into clinical development, offering a potential new treatment option for COPD patients.

  • #ACROHighlights [Featured Product] 🧠 New Breakthrough in Parkinson’s Research! 🧠 On Feb 20, Professor Jin-Tai Yu’s team published a groundbreaking study in Science, identifying FAM171A2 as a new therapeutic target for Parkinson’s disease. Their research showed that FAM171A2 overexpression worsens α-synuclein pathology, leading to dopaminergic neuron damage and motor dysfunction in a mouse model. To support cutting-edge neurodegenerative disease research, we offer α-synuclein PFFs for developing reliable in vivo and in vitro models. Click to discover more: https://lnkd.in/grJuAKWY Let’s accelerate discoveries together! 🚀 #ParkinsonsDisease #Neurodegeneration #αSynuclein #Science #Biopharma #ResearchTools

    • No alternative text description for this image
  • #MeetwithACRO [ACRO Event - UK] Day 2 at NextGen Biomed 2025! 🎉 A huge thank you to everyone who stopped by Booth #30 yesterday and tried their luck on our prize wheel! It’s been great connecting with so many brilliant minds in the industry. Haven’t had a chance to visit yet? There’s still time! Come by to check out our popular horseshoe crab plush bag and learn more about our Recombinant Factor C Endotoxin Fluorescent Assay Kit—a sustainable, animal-free alternative for endotoxin testing. Looking forward to another exciting day of conversations and innovations! #NextGenBiomed2025 #NGB2025 #EndotoxinTesting #RecombinantFactorC #Biotech #LifeSciences #ACROBiosystems #SaveTheHorseshoeCrab

    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for ACROBiosystems

    30,464 followers

    🔊 ACRO is thrilled to attend Forum Labo Paris 2025 that takes place 25th-27th March! If you will also join, make sure to be part of our workshop on 25th March starting at 13:00 in ROOM 5. 🛎️ Join us for this session dedicated to organoids models and co-animated by experts from ACRO and Paris-Based Orakl Oncology. We hope to see you there! 🤝 📋 Workshop details: https://lnkd.in/dzmxyjZf #forumlaboparis #organoids

  • View organization page for ACROBiosystems

    30,464 followers

    #MeetwithACRO [ACRO Event - UK] 🚀 5 Reasons to Visit Us at #AdvancedTherapies 2025! 📍 Booth #39 | ExCeL London | 18-19 March Here’s why you can’t miss ACROBiosystems: 🔹 Exclusive Speaker Session – Learn how laminins enhance iPSC-based cell therapy manufacturing. - 18 March | 11:00–11:20 AM | Innovation Stage (Track 2) 🔹 Scientific Poster Session – Explore our feeder-free iPSC-to-T cell differentiation system for #GMP applications. -  19 March | Morning Coffee Break | Poster #73 🔹 GMP-Ready Solutions – Get hands-on with our latest GMP-grade reagents, iPSC culture systems, and QC tools. 🔹 Engagement & Giveaways ✅ LinkedIn Follow Event – Follow us & grab an exclusive llama keychain! ✅ Prize Wheel Challenge – Scan, submit & spin to win premium swag! 🔹 Let’s Talk Partnerships! – We’re looking to collaborate with biotech, CDMOs & process development teams on: 📌 GMP solutions | 📌 Custom reagents | 📌 Co-development projects See you in London! #AdvancedTherapies2025 #ACROBiosystems #CGTManufacturing #CMC #CellTherapy #GeneTherapy

  • #MeetwithACRO [ACRO Event - UK] Day 1 at NextGen Biomed 2025! 🎉 We’re all set up at Booth #30 and excited to connect with you! Come meet our experts, Theo Vogiatzoglou and Mourad FERHAT, Ph.D to discuss how ACROBiosystems can support your research with high-quality reagents and solutions. And don’t miss out on the fun—our Lucky Wheel is here! 🎡 Spin for a chance to win our adorable horseshoe crab plush bag and learn how we can work together to help protect this vital species. Stop by, say hello, and let’s make this an inspiring event! #NextGenBiomed2025 #NGB2025 #Biotech #Pharma #LifeSciences #ACROBiosystems #SaveTheHorseshoeCrab

    • No alternative text description for this image
    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs

Funding

ACROBiosystems 3 total rounds

Last Round

Series B
See more info on crunchbase